SciELO - Scientific Electronic Library Online

 
vol.16 issue1Clinical and laboratory characteristics associated with referral of hospitalized elderly to palliative careCriminal liability of medical professionals in the São Paulo State Court of Appeals author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Einstein (São Paulo)

Print version ISSN 1679-4508On-line version ISSN 2317-6385

Abstract

CHADE, Milca Cezar et al. Evaluation of survivin immunoexpression in the differentiation of high- and low-grade breast ductal carcinoma in situ. Einstein (São Paulo) [online]. 2018, vol.16, n.1, eAO4065.  Epub Apr 23, 2018. ISSN 1679-4508.  http://dx.doi.org/10.1590/s1679-45082018ao4065.

Objective

To evaluate the expression of survivin protein in low- and high-grade ductal carcinoma in situ.

Methods

Breast tissue fragments obtained by incisional biopsy and surgical procedures of 37 women with ductal carcinoma in situ of the breast were subdivided into two groups: Group A, composed of women with low-grade ductal carcinoma in situ, and Group B, women with high-grade ductal carcinoma in situ. Survivin protein expression test was performed by immunohistochemistry, using a monoclonal antibody clone I2C4. The criterion to evaluate survivin immunoexpression was based on the percentage of neoplastic cells that presented brown-gold staining. This criterion was positive when the percentage of stained cells was ≥10%.

Results

The survivin protein was expressed in 22 out of 24 cases of high-grade ductal carcinoma in situ (78%), whereas, in Group A, of low-grade ductal carcinoma in situ (n=13), it was positive in only 6 cases (21.40%; p=0.004).

Conclusion

The frequency of expression of survivin was significantly higher in the group of patients with high-grade ductal carcinoma in situ compared to those in the low-grade ductal carcinoma in situ group.

Keywords : Inhibitor of apoptosis proteins; Carcinoma, intraductal, noninfiltrating; Biomarkers, tumor; Neoplasm proteins; Breast neoplasms.

        · abstract in Portuguese     · text in English | Portuguese     · English ( pdf ) | Portuguese ( pdf )